⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNXP News
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
globenewswire.com
TNXP
Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
globenewswire.com
TNXP
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
globenewswire.com
TNXP
Form 8-K
sec.gov
TNXP
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
globenewswire.com
TNXP
Form 8-K
sec.gov
TNXP
Form 8-K
sec.gov
TNXP
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
globenewswire.com
TNXP
Form 8-K
sec.gov
TNXP
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
globenewswire.com
TNXP